- citati u SCIndeksu: [6]
- citati u CrossRef-u:[2]
- citati u Google Scholaru:[
 ]
- posete u poslednjih 30 dana:31
- preuzimanja u poslednjih 30 dana:11
|
|
|
2016, vol. 35, br. 3, str. 282-292
|
|
Povezanost kardiovaskularnog rizika sa tradicionalnim i netradicionalnim kardiometaboličkim parametrima kod gojaznih adolescentkinja
Relationship between cardiovascular risk score and traditional and nontraditional cardiometabolic parameters in Obese adolescent girls
aPrimary Health Care Center, Podgorica, Montenegro bUniverzitet u Beogradu, Medicinski fakultet, Institut za medicinsku statistiku i informatiku, Srbija cKlinički centar Niš, Klinika za dečje interne bolesti, Srbija dUniverzitet u Beogradu, Farmaceutski fakultet, Institut za medicinsku biohemiju, Srbija
e-adresa: jkotur@pharmacy.bg.ac.rs
Projekat: Interaktivna uloga dislipidemije, oksidativnog stresa i inflamacije u aterosklerozi i drugim bolestima: genetički i biohemijski markeri (MPNTR - 175035)
Sažetak
Uvod: Kako je skor kardiovaskularnog (KV) rizika često potcenjen kod dece i adolescenata, naročito u zemljama u razvoju, kakva je Crna Gora, gde postoji jaka interakcija između genetski uslovljenog KV rizika i sredine, cilj ove studije je bio da se proceni KV rizik kod zdravih adolescentkinja. Takođe, cilj je bio i da se ispitaju neki novi KV faktori rizika u interakciji sa tradicionalnim, kao što je gojaznost. Preciznije, imali smo za cilj da ispitamo uticaj niskih vrednosti bilirubina, rutinskog biohemijskog parametra, kao dodatnog faktora rizika za aterosklerozu u adultnom dobu. Metode: Ukupno 45 gojaznih adolescentkinja, srednje starosne dobi 17,8± 1,22 godina, i 45 normalno uhranjenih adolescentkinja, uparenih po godinama starosti, nepušača, uključeno je u studiju. Mereni su antropometrijski i biohemijski parametri. Skor kardiovaskularnog rizika (CVRS) računat je dodavanjem poena za svaki faktor rizika (pol, HDL-holesterol, non-HDL-holesterol, krvni pritisak i glikemija našte). Rezultati: Utvrđena je statistički značajna pozitivna povezanost između CVRS i ALT, hsCRP i TG/HDL-holesterola (P<0,001). Višestruka linearna regresiona analiza je pokazala da su veći obim struka i viši LDL-holesterol, a niži HDL-holesterol nezavisni prediktori nižih vrednosti bilirubina (R2 = 0,603, P<0,001). Zaključak: Gojazne adolescentkinje imaju povećan rizik za KV bolesti u kasnijem dobu. Pored tradicionalnih faktora rizika, ukupni bilirubin može imati potencijal da diskriminiše između niskog i većeg rizika za KV promene kod zdravih adolescentkinja.
Abstract
Background: Since the cardiovascular (CV) risk score in the young population, children and adolescents, is underestimated, especially in developing countries such as Montenegro, where a strong interaction exists between the genetically conditioned CV risk and environmental factors, the purpose of this study was to estimate CV risk in apparently healthy adolescent girls. Moreover, we aimed to test some new, emerging CV risk factors and their interaction with the traditional ones, such as obesity. Precisely, we aimed to assess the impact of low bilirubin levels, as a routine biochemical parameter, as an additional risk factor for atherosclerotic disease in the adult phase. Methods: Forty-five obese adolescent girls (mean age 17.8± 1.22 years) and forty-five ageand sex-matched normal weight controls, all nonsmokers, were included. Anthropometric and biochemical parameters were measured. Cardiovascular Risk Score (CVRS) was calculated by adding the points for each risk factor (e.g. sex, HDL-c, non-HDLc, blood pressure and fasting glycemia). Results: A significant positive relationship between CVRS and ALT, hsCRP and TG/HDL-c, but an opposite relationship between CVRS and total bilirubin were found (P< 0.001). Multiple linear regression analysis showed that higher waist circumference (WC) and LDL-c, but lower HDL-c were independent predictors of lower bilirubin values (adjusted R2= 0.603, P< 0.001). Conclusions: Obese adolescent girls are at an increased risk of cardiovascular disease late in life. In addition to the traditional risk factors, total bilirubin may have the potential to discriminate between low and higher risk for cardiovascular disturbances in healthy adolescent girls.
|
|
|
|
Reference
|
|
  
|
Abraham, N.G., Kappas, A. (2008) Pharmacological and clinical aspects of heme oxygenase. Pharmacological Reviews, 60(1), 79-127
|
|
|
Belo, L., Nascimento, H., Kohlova, M., Bronze-Da-rocha, E., Fernandes, J., Costa, E., Catarino, C., Aires, L., Mansilha, H.F., Rocha-Pereira, P., Quintanilha, A., Rêgo, C., Santos-Silva, A. (2014) Body fat percentage is a major determinant of total bilirubin independently of UGT1a1*28 polymorphism in young obese. PLoS One, 9(6), e98467-e98467
|
|
|
Bulmer, A.C., Verkade, H.J., Wagner, K.H. (2013) Bilirubin and beyond: A review of lipid status in Gilbert's syndrome and its relevance to cardiovascular disease protection. Progress in Lipid Research, 52(2), 193-205
|
|
|
Deetman, P.E., Bakker, S.J.L. (2015) Dullaart RPF High sensitive C-reactive protein and serum amyloid A are inversely related to serum bilirubin: Effect-modification by metabolic syndrome. Cardiovasc Diabetol, 20, 166-166
|
|
|
Gul, M., Kalkan, A.K., Uyarel, H. (2014) Serum bilirubin: A friendly or an enemy against cardiovascular diseases?. Journal of Critical Care, 29(2), 305-306
|
|
|
Herouvi, D., Karanasios, E., Karayianni, C., Karavanaki, K. (2013) Cardiovascular disease in childhood: The role of obesity. European Journal of Pediatrics, 172(6), 721-732
|
|
4
|
Hosmer, D., Lemeshow, S., Sturdivant, R.X. (2013) Applied logistic regression. New York, NY: John Wiley & Sons Inc, 3rd ed
|
|
|
Hwang, H.J., Kim, S.H. (2010) Inverse relationship between fasting direct bilirubin and metabolic syndrome in Korean adults. Clinica Chimica Acta, 411(19-20), 1496-1501
|
|
|
Jenko-Pražnikar, Z., Petelin, A., Jurdana, M., Žiberna, L. (2013) Serum bilirubin levels are lower in overweight asymptomatic middle-aged adults: An early indicator of metabolic syndrome?. Metabolism, 62(7), 976-985
|
|
1
|
Jørgensen, M.E., Torp-Pedersen, C., Finer, N., Caterson, I., James, W.P.T., Legler, U.F., Andersson, C. (2014) Association between serum bilirubin and cardiovascular disease in an overweight high risk population from the SCOUT trial. Nutrition, Metabolism and Cardiovascular Diseases, 24(6), 656-662
|
|
4   
|
Kocova, M., Sukarova-Angelovska, E., Tanaskoska, M., Palcevska-Kocevska, S., Krstevska, M. (2015) Metabolic setup and risks in obese children. Journal of Medical Biochemistry, vol. 34, br. 1, str. 31-37
|
|
|
Lay, L.S., Simard, G., Martinez, M.C., Andriantsitohaina, R. (2014) Oxidative stress and metabolic pathologies: From an adipocentric point of view. Oxid Med Cell Longev, 2014, 908539
|
|
|
Lin, J.P., Vitek, L., Schwertner, H.A. (2010) Serum bilirubin and genes controlling bilirubin concentrations as biomarkers for cardiovascular disease. Clinical Chemistry, 56(10), 1535-1543
|
|
|
McArdle, P.F., Whitcomb, B.W., Tanner, K., Mitchell, B.D., Shuldiner, A.R., Parsa, A. (2012) Association between bilirubin and cardiovascular disease risk factors: Using Mendelian randomization to assess causal inference. BMC Cardiovascular Disorders, 12(1), 16-16
|
|
1
|
McMahan, C.A., Gidding, S.S., Fayad, Z.A., Zieske, A.W., Malcom, G.T., Tracy, R.E., i dr. (2005) Risk scores predict atherosclerotic lesions in young people. Archives of Internal Medicine, 165(8), 883-890
|
|
|
Morita, T. (2005) Hemeoxygenase and atherosclerosis. Arterioscler Thromb Vasc Biol, 25, 1786-1795
|
|
1
|
Oda, E. (2015) Cross-sectional and longitudinal associations between serum bilirubin and dyslipidemia in a health screening population. Atherosclerosis, 239(1), 31-37
|
|
1
|
Ridker, P.M. (2003) Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation, 107(3), 363-369
|
|
2
|
Savini, I., Catani, M.V., Evangelista, D., Gasperi, V., Avigliano, L. (2013) Obesity-associated oxidative stress: Strategies finalized to improve redox state. International Journal of Molecular Sciences, 14(5), 10497-10538
|
|
1
|
Schindhelm, R.K., Dekker, J.M., Nijpels, G., Bouter, L.M., Stehouwer, C.D.A., Heine, R.J., Diamant, M. (2007) Alanine aminotransferase predicts coronary heart disease events: A 10-year follow-up of the Hoorn Study. Atherosclerosis, 191(2), 391-396
|
|
|
Song, Y.S., Koo, B.K., Cho, N.H., Moon, M.K. (2014) Effect of low serum total bilirubin levels (≤0.32 mg/dl) on risk of coronary artery disease in patients with metabolic syndrome. American Journal of Cardiology, 114(11), 1695-1700
|
|
|
Tatami, Y., Suzuki, S., Ishii, H., Shibata, Y., Osugi, N., Ota, T., Kawamura, Y., Tanaka, A., Takeshita, K., Murohara, T. (2014) Impact of serum bilirubin levels on carotid atherosclerosis in patients with coronary artery disease. IJC Metabolic & Endocrine, 5, 24-27
|
|
|
Urbina, E.M., Khoury, P.R., McCoy, C.E., Dolan, L.M., Daniels, S.R., Kimball, T.R. (2013) Triglyceride to HDL-C ratio and increased arterial stiffness in children, adolescents, and young adults. Pediatrics, 131, 1-9
|
|
|
Vitek, L. (2012) The role of bilirubin in diabetes, metabolic syndrome, and cardiovascular diseases. Frontiers in Pharmacology, 3, 55-55
|
|
|
World Health Organization (2007) Growth reference 5 -19 years. http://www.who.int/growthref/who2007_bmi_for_ age/en
|
|
|
World Medical Association (1997) Declaration of Helsinki: Recommendations guiding physicians in biomedical research involving human subjects. JAMA, 277, 925-926
|
|
3
|
Zdravković, V., Sajić, S., Mitrović, J., Stefanović, I., Pavićević, P., Nikolić, D., Dimić, J., Lalić, N.M. (2015) The diagnosis of prediabetes in adolescents. Journal of Medical Biochemistry, vol. 34, br. 1, str. 38-45
|
|
|
Zimmet, P., Alberti, G.M.K., Kaufman, F., Tajima, N., Silink, M., Arslanian, S., Wong, G., Bennett, P., Shaw, J., Caprio, S. (2007) The metabolic syndrome in children and adolescents: An IDF consensus report. Pediatric diabetes, 8(5), 299-306
|
|
|
|
|